nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—migraine—Prednisone—psoriasis	0.76	1	CpDpCtD
Orphenadrine—CYP2B6—Cholecalciferol—psoriasis	0.0306	0.201	CbGbCtD
Orphenadrine—CYP3A4—Calcitriol—psoriasis	0.0182	0.12	CbGbCtD
Orphenadrine—CYP3A4—Methoxsalen—psoriasis	0.0142	0.093	CbGbCtD
Orphenadrine—CYP2E1—Dexamethasone—psoriasis	0.0134	0.088	CbGbCtD
Orphenadrine—CYP2B6—Dexamethasone—psoriasis	0.0132	0.0868	CbGbCtD
Orphenadrine—CYP3A4—Cholecalciferol—psoriasis	0.00939	0.0616	CbGbCtD
Orphenadrine—CYP3A4—Mycophenolate mofetil—psoriasis	0.00815	0.0534	CbGbCtD
Orphenadrine—CYP3A4—Triamcinolone—psoriasis	0.00815	0.0534	CbGbCtD
Orphenadrine—CYP3A4—Betamethasone—psoriasis	0.00699	0.0458	CbGbCtD
Orphenadrine—CYP3A4—Prednisolone—psoriasis	0.0069	0.0452	CbGbCtD
Orphenadrine—CYP3A4—Hydrocortisone—psoriasis	0.00654	0.0429	CbGbCtD
Orphenadrine—CYP3A4—Prednisone—psoriasis	0.00651	0.0427	CbGbCtD
Orphenadrine—CYP3A4—Cyclosporine—psoriasis	0.00617	0.0405	CbGbCtD
Orphenadrine—CYP3A4—Dexamethasone—psoriasis	0.00406	0.0267	CbGbCtD
Orphenadrine—Epigastric discomfort—Calcitriol—psoriasis	0.00335	0.04	CcSEcCtD
Orphenadrine—Gastric irritation—Hydroxyurea—psoriasis	0.00317	0.0379	CcSEcCtD
Orphenadrine—Epigastric discomfort—Hydroxyurea—psoriasis	0.00234	0.0279	CcSEcCtD
Orphenadrine—Gastric irritation—Prednisone—psoriasis	0.00142	0.017	CcSEcCtD
Orphenadrine—Hypersensitivity—Calcipotriol—psoriasis	0.00117	0.0139	CcSEcCtD
Orphenadrine—Pruritus—Calcipotriol—psoriasis	0.00112	0.0134	CcSEcCtD
Orphenadrine—Epigastric discomfort—Prednisone—psoriasis	0.00105	0.0125	CcSEcCtD
Orphenadrine—Drowsiness—Calcitriol—psoriasis	0.000984	0.0118	CcSEcCtD
Orphenadrine—Skin disorder—Clobetasol propionate—psoriasis	0.000961	0.0115	CcSEcCtD
Orphenadrine—Mydriasis—Prednisolone—psoriasis	0.00095	0.0113	CcSEcCtD
Orphenadrine—Anaphylactic shock—Beclomethasone—psoriasis	0.000901	0.0108	CcSEcCtD
Orphenadrine—Skin disorder—Fluocinonide—psoriasis	0.000867	0.0104	CcSEcCtD
Orphenadrine—Tension—Methoxsalen—psoriasis	0.000847	0.0101	CcSEcCtD
Orphenadrine—Pruritus—Tazarotene—psoriasis	0.000826	0.00986	CcSEcCtD
Orphenadrine—Aplastic anaemia—Mycophenolate mofetil—psoriasis	0.000763	0.00911	CcSEcCtD
Orphenadrine—Hypersensitivity—Clobetasol propionate—psoriasis	0.000729	0.00871	CcSEcCtD
Orphenadrine—Urticaria—Beclomethasone—psoriasis	0.000716	0.00855	CcSEcCtD
Orphenadrine—Agitation—Calcitriol—psoriasis	0.000707	0.00844	CcSEcCtD
Orphenadrine—Pruritus—Clobetasol propionate—psoriasis	0.0007	0.00836	CcSEcCtD
Orphenadrine—Drowsiness—Hydroxyurea—psoriasis	0.000688	0.00821	CcSEcCtD
Orphenadrine—Skin disorder—Methoxsalen—psoriasis	0.000684	0.00817	CcSEcCtD
Orphenadrine—Tension—Acitretin—psoriasis	0.000672	0.00802	CcSEcCtD
Orphenadrine—Hypersensitivity—Fluocinonide—psoriasis	0.000658	0.00785	CcSEcCtD
Orphenadrine—Vision blurred—Acitretin—psoriasis	0.000645	0.0077	CcSEcCtD
Orphenadrine—Vision blurred—Fluocinolone Acetonide—psoriasis	0.000643	0.00768	CcSEcCtD
Orphenadrine—Pruritus—Fluocinonide—psoriasis	0.000631	0.00754	CcSEcCtD
Orphenadrine—Anaphylactic shock—Calcitriol—psoriasis	0.000628	0.0075	CcSEcCtD
Orphenadrine—Headache—Clobetasol propionate—psoriasis	0.00062	0.0074	CcSEcCtD
Orphenadrine—Hallucination—Hydroxyurea—psoriasis	0.000614	0.00733	CcSEcCtD
Orphenadrine—Skin disorder—Calcitriol—psoriasis	0.00061	0.00728	CcSEcCtD
Orphenadrine—Dizziness—Beclomethasone—psoriasis	0.000596	0.00711	CcSEcCtD
Orphenadrine—Dizziness—Fluocinonide—psoriasis	0.00059	0.00705	CcSEcCtD
Orphenadrine—Feeling abnormal—Methoxsalen—psoriasis	0.00058	0.00693	CcSEcCtD
Orphenadrine—Headache—Beclomethasone—psoriasis	0.000564	0.00674	CcSEcCtD
Orphenadrine—Urticaria—Methoxsalen—psoriasis	0.00056	0.00668	CcSEcCtD
Orphenadrine—Headache—Fluocinonide—psoriasis	0.000559	0.00668	CcSEcCtD
Orphenadrine—Somnolence—Calcitriol—psoriasis	0.000558	0.00667	CcSEcCtD
Orphenadrine—Skin disorder—Acitretin—psoriasis	0.000543	0.00648	CcSEcCtD
Orphenadrine—Constipation—Calcitriol—psoriasis	0.000537	0.00641	CcSEcCtD
Orphenadrine—Nausea—Beclomethasone—psoriasis	0.000535	0.00639	CcSEcCtD
Orphenadrine—Hypersensitivity—Methoxsalen—psoriasis	0.000519	0.0062	CcSEcCtD
Orphenadrine—Hallucination—Mycophenolic acid—psoriasis	0.000514	0.00614	CcSEcCtD
Orphenadrine—Urticaria—Calcitriol—psoriasis	0.000499	0.00596	CcSEcCtD
Orphenadrine—Pruritus—Methoxsalen—psoriasis	0.000498	0.00595	CcSEcCtD
Orphenadrine—Somnolence—Acitretin—psoriasis	0.000497	0.00593	CcSEcCtD
Orphenadrine—Constipation—Acitretin—psoriasis	0.000478	0.0057	CcSEcCtD
Orphenadrine—Dizziness—Methoxsalen—psoriasis	0.000466	0.00556	CcSEcCtD
Orphenadrine—Hypersensitivity—Calcitriol—psoriasis	0.000463	0.00552	CcSEcCtD
Orphenadrine—Feeling abnormal—Acitretin—psoriasis	0.00046	0.0055	CcSEcCtD
Orphenadrine—Asthenia—Calcitriol—psoriasis	0.00045	0.00538	CcSEcCtD
Orphenadrine—Pruritus—Calcitriol—psoriasis	0.000444	0.00531	CcSEcCtD
Orphenadrine—Urticaria—Acitretin—psoriasis	0.000444	0.0053	CcSEcCtD
Orphenadrine—Tension—Mycophenolic acid—psoriasis	0.000442	0.00527	CcSEcCtD
Orphenadrine—Headache—Methoxsalen—psoriasis	0.000441	0.00527	CcSEcCtD
Orphenadrine—Aplastic anaemia—Methotrexate—psoriasis	0.000432	0.00516	CcSEcCtD
Orphenadrine—Skin disorder—Hydroxyurea—psoriasis	0.000426	0.00509	CcSEcCtD
Orphenadrine—Vision blurred—Mycophenolic acid—psoriasis	0.000424	0.00507	CcSEcCtD
Orphenadrine—Tremor—Mycophenolic acid—psoriasis	0.000422	0.00504	CcSEcCtD
Orphenadrine—Nausea—Methoxsalen—psoriasis	0.000418	0.005	CcSEcCtD
Orphenadrine—Agitation—Mycophenolic acid—psoriasis	0.000414	0.00494	CcSEcCtD
Orphenadrine—Hypersensitivity—Acitretin—psoriasis	0.000412	0.00491	CcSEcCtD
Orphenadrine—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.00041	0.0049	CcSEcCtD
Orphenadrine—Hallucination—Mycophenolate mofetil—psoriasis	0.000406	0.00485	CcSEcCtD
Orphenadrine—Asthenia—Acitretin—psoriasis	0.000401	0.00479	CcSEcCtD
Orphenadrine—Vomiting—Calcitriol—psoriasis	0.000399	0.00477	CcSEcCtD
Orphenadrine—Palpitations—Mycophenolic acid—psoriasis	0.000398	0.00475	CcSEcCtD
Orphenadrine—Pruritus—Acitretin—psoriasis	0.000395	0.00472	CcSEcCtD
Orphenadrine—Pruritus—Fluocinolone Acetonide—psoriasis	0.000394	0.00471	CcSEcCtD
Orphenadrine—Headache—Calcitriol—psoriasis	0.000393	0.0047	CcSEcCtD
Orphenadrine—Somnolence—Hydroxyurea—psoriasis	0.00039	0.00466	CcSEcCtD
Orphenadrine—Constipation—Hydroxyurea—psoriasis	0.000375	0.00448	CcSEcCtD
Orphenadrine—Nausea—Calcitriol—psoriasis	0.000373	0.00445	CcSEcCtD
Orphenadrine—Confusional state—Mycophenolic acid—psoriasis	0.00037	0.00442	CcSEcCtD
Orphenadrine—Hallucination—Hydrocortisone—psoriasis	0.00037	0.00442	CcSEcCtD
Orphenadrine—Dizziness—Acitretin—psoriasis	0.000369	0.00441	CcSEcCtD
Orphenadrine—Dizziness—Fluocinolone Acetonide—psoriasis	0.000368	0.0044	CcSEcCtD
Orphenadrine—Feeling abnormal—Hydroxyurea—psoriasis	0.000361	0.00432	CcSEcCtD
Orphenadrine—Tachycardia—Mycophenolic acid—psoriasis	0.000358	0.00428	CcSEcCtD
Orphenadrine—Tension—Cyclosporine—psoriasis	0.000357	0.00427	CcSEcCtD
Orphenadrine—Skin disorder—Mycophenolic acid—psoriasis	0.000357	0.00426	CcSEcCtD
Orphenadrine—Vomiting—Acitretin—psoriasis	0.000355	0.00424	CcSEcCtD
Orphenadrine—Vomiting—Fluocinolone Acetonide—psoriasis	0.000354	0.00423	CcSEcCtD
Orphenadrine—Headache—Acitretin—psoriasis	0.00035	0.00418	CcSEcCtD
Orphenadrine—Headache—Fluocinolone Acetonide—psoriasis	0.000349	0.00417	CcSEcCtD
Orphenadrine—Tension—Mycophenolate mofetil—psoriasis	0.000349	0.00416	CcSEcCtD
Orphenadrine—Vision blurred—Cyclosporine—psoriasis	0.000343	0.0041	CcSEcCtD
Orphenadrine—Tremor—Cyclosporine—psoriasis	0.000341	0.00407	CcSEcCtD
Orphenadrine—Agitation—Cyclosporine—psoriasis	0.000335	0.004	CcSEcCtD
Orphenadrine—Tremor—Mycophenolate mofetil—psoriasis	0.000333	0.00397	CcSEcCtD
Orphenadrine—Nausea—Acitretin—psoriasis	0.000332	0.00396	CcSEcCtD
Orphenadrine—Nausea—Fluocinolone Acetonide—psoriasis	0.000331	0.00395	CcSEcCtD
Orphenadrine—Somnolence—Mycophenolic acid—psoriasis	0.000327	0.0039	CcSEcCtD
Orphenadrine—Agitation—Mycophenolate mofetil—psoriasis	0.000326	0.0039	CcSEcCtD
Orphenadrine—Hypersensitivity—Hydroxyurea—psoriasis	0.000323	0.00386	CcSEcCtD
Orphenadrine—Hallucination—Betamethasone—psoriasis	0.000316	0.00377	CcSEcCtD
Orphenadrine—Hallucination—Dexamethasone—psoriasis	0.000316	0.00377	CcSEcCtD
Orphenadrine—Asthenia—Hydroxyurea—psoriasis	0.000315	0.00376	CcSEcCtD
Orphenadrine—Constipation—Mycophenolic acid—psoriasis	0.000314	0.00375	CcSEcCtD
Orphenadrine—Palpitations—Mycophenolate mofetil—psoriasis	0.000314	0.00375	CcSEcCtD
Orphenadrine—Vision blurred—Prednisolone—psoriasis	0.000312	0.00373	CcSEcCtD
Orphenadrine—Feeling abnormal—Mycophenolic acid—psoriasis	0.000303	0.00361	CcSEcCtD
Orphenadrine—Confusional state—Cyclosporine—psoriasis	0.0003	0.00358	CcSEcCtD
Orphenadrine—Anaphylactic shock—Cyclosporine—psoriasis	0.000297	0.00355	CcSEcCtD
Orphenadrine—Confusional state—Mycophenolate mofetil—psoriasis	0.000292	0.00349	CcSEcCtD
Orphenadrine—Dizziness—Hydroxyurea—psoriasis	0.00029	0.00346	CcSEcCtD
Orphenadrine—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.00029	0.00346	CcSEcCtD
Orphenadrine—Skin disorder—Cyclosporine—psoriasis	0.000289	0.00345	CcSEcCtD
Orphenadrine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000283	0.00338	CcSEcCtD
Orphenadrine—Skin disorder—Mycophenolate mofetil—psoriasis	0.000282	0.00336	CcSEcCtD
Orphenadrine—Vomiting—Hydroxyurea—psoriasis	0.000279	0.00333	CcSEcCtD
Orphenadrine—Hallucination—Prednisone—psoriasis	0.000275	0.00329	CcSEcCtD
Orphenadrine—Headache—Hydroxyurea—psoriasis	0.000275	0.00328	CcSEcCtD
Orphenadrine—Anaphylactic shock—Prednisolone—psoriasis	0.00027	0.00323	CcSEcCtD
Orphenadrine—Somnolence—Cyclosporine—psoriasis	0.000264	0.00315	CcSEcCtD
Orphenadrine—Anaphylactic shock—Hydrocortisone—psoriasis	0.000264	0.00315	CcSEcCtD
Orphenadrine—Tachycardia—Prednisolone—psoriasis	0.000264	0.00315	CcSEcCtD
Orphenadrine—Asthenia—Mycophenolic acid—psoriasis	0.000264	0.00315	CcSEcCtD
Orphenadrine—Nausea—Hydroxyurea—psoriasis	0.00026	0.00311	CcSEcCtD
Orphenadrine—Pruritus—Mycophenolic acid—psoriasis	0.00026	0.0031	CcSEcCtD
Orphenadrine—Tachycardia—Hydrocortisone—psoriasis	0.000258	0.00308	CcSEcCtD
Orphenadrine—Somnolence—Mycophenolate mofetil—psoriasis	0.000258	0.00308	CcSEcCtD
Orphenadrine—Drowsiness—Methotrexate—psoriasis	0.000257	0.00307	CcSEcCtD
Orphenadrine—Skin disorder—Hydrocortisone—psoriasis	0.000256	0.00306	CcSEcCtD
Orphenadrine—Constipation—Cyclosporine—psoriasis	0.000254	0.00303	CcSEcCtD
Orphenadrine—Anaphylactic shock—Triamcinolone—psoriasis	0.000249	0.00297	CcSEcCtD
Orphenadrine—Constipation—Mycophenolate mofetil—psoriasis	0.000248	0.00296	CcSEcCtD
Orphenadrine—Feeling abnormal—Cyclosporine—psoriasis	0.000245	0.00292	CcSEcCtD
Orphenadrine—Dizziness—Mycophenolic acid—psoriasis	0.000243	0.0029	CcSEcCtD
Orphenadrine—Tachycardia—Triamcinolone—psoriasis	0.000243	0.0029	CcSEcCtD
Orphenadrine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000239	0.00285	CcSEcCtD
Orphenadrine—Urticaria—Cyclosporine—psoriasis	0.000236	0.00282	CcSEcCtD
Orphenadrine—Vomiting—Mycophenolic acid—psoriasis	0.000234	0.00279	CcSEcCtD
Orphenadrine—Urticaria—Mycophenolate mofetil—psoriasis	0.00023	0.00275	CcSEcCtD
Orphenadrine—Headache—Mycophenolic acid—psoriasis	0.00023	0.00275	CcSEcCtD
Orphenadrine—Vision blurred—Prednisone—psoriasis	0.000227	0.00271	CcSEcCtD
Orphenadrine—Anaphylactic shock—Dexamethasone—psoriasis	0.000226	0.00269	CcSEcCtD
Orphenadrine—Anaphylactic shock—Betamethasone—psoriasis	0.000226	0.00269	CcSEcCtD
Orphenadrine—Feeling abnormal—Prednisolone—psoriasis	0.000223	0.00266	CcSEcCtD
Orphenadrine—Agitation—Prednisone—psoriasis	0.000221	0.00264	CcSEcCtD
Orphenadrine—Tachycardia—Betamethasone—psoriasis	0.00022	0.00263	CcSEcCtD
Orphenadrine—Tachycardia—Dexamethasone—psoriasis	0.00022	0.00263	CcSEcCtD
Orphenadrine—Hypersensitivity—Cyclosporine—psoriasis	0.000219	0.00261	CcSEcCtD
Orphenadrine—Nausea—Mycophenolic acid—psoriasis	0.000218	0.00261	CcSEcCtD
Orphenadrine—Feeling abnormal—Hydrocortisone—psoriasis	0.000218	0.0026	CcSEcCtD
Orphenadrine—Urticaria—Prednisolone—psoriasis	0.000215	0.00257	CcSEcCtD
Orphenadrine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000214	0.00255	CcSEcCtD
Orphenadrine—Asthenia—Cyclosporine—psoriasis	0.000213	0.00255	CcSEcCtD
Orphenadrine—Pruritus—Cyclosporine—psoriasis	0.00021	0.00251	CcSEcCtD
Orphenadrine—Urticaria—Hydrocortisone—psoriasis	0.00021	0.00251	CcSEcCtD
Orphenadrine—Asthenia—Mycophenolate mofetil—psoriasis	0.000208	0.00248	CcSEcCtD
Orphenadrine—Pruritus—Mycophenolate mofetil—psoriasis	0.000205	0.00245	CcSEcCtD
Orphenadrine—Feeling abnormal—Triamcinolone—psoriasis	0.000205	0.00245	CcSEcCtD
Orphenadrine—Hypersensitivity—Prednisolone—psoriasis	0.000199	0.00238	CcSEcCtD
Orphenadrine—Urticaria—Triamcinolone—psoriasis	0.000198	0.00236	CcSEcCtD
Orphenadrine—Dizziness—Cyclosporine—psoriasis	0.000196	0.00235	CcSEcCtD
Orphenadrine—Anaphylactic shock—Prednisone—psoriasis	0.000196	0.00235	CcSEcCtD
Orphenadrine—Hypersensitivity—Hydrocortisone—psoriasis	0.000195	0.00232	CcSEcCtD
Orphenadrine—Tachycardia—Prednisone—psoriasis	0.000192	0.00229	CcSEcCtD
Orphenadrine—Dizziness—Mycophenolate mofetil—psoriasis	0.000192	0.00229	CcSEcCtD
Orphenadrine—Skin disorder—Prednisone—psoriasis	0.000191	0.00228	CcSEcCtD
Orphenadrine—Vision blurred—Methotrexate—psoriasis	0.00019	0.00226	CcSEcCtD
Orphenadrine—Asthenia—Hydrocortisone—psoriasis	0.000189	0.00226	CcSEcCtD
Orphenadrine—Vomiting—Cyclosporine—psoriasis	0.000189	0.00226	CcSEcCtD
Orphenadrine—Pruritus—Hydrocortisone—psoriasis	0.000187	0.00223	CcSEcCtD
Orphenadrine—Headache—Cyclosporine—psoriasis	0.000186	0.00222	CcSEcCtD
Orphenadrine—Feeling abnormal—Betamethasone—psoriasis	0.000186	0.00222	CcSEcCtD
Orphenadrine—Feeling abnormal—Dexamethasone—psoriasis	0.000186	0.00222	CcSEcCtD
Orphenadrine—Vomiting—Mycophenolate mofetil—psoriasis	0.000184	0.0022	CcSEcCtD
Orphenadrine—Hypersensitivity—Triamcinolone—psoriasis	0.000183	0.00219	CcSEcCtD
Orphenadrine—Headache—Mycophenolate mofetil—psoriasis	0.000182	0.00217	CcSEcCtD
Orphenadrine—Urticaria—Dexamethasone—psoriasis	0.000179	0.00214	CcSEcCtD
Orphenadrine—Urticaria—Betamethasone—psoriasis	0.000179	0.00214	CcSEcCtD
Orphenadrine—Dizziness—Prednisolone—psoriasis	0.000179	0.00214	CcSEcCtD
Orphenadrine—Asthenia—Triamcinolone—psoriasis	0.000178	0.00213	CcSEcCtD
Orphenadrine—Nausea—Cyclosporine—psoriasis	0.000176	0.00211	CcSEcCtD
Orphenadrine—Pruritus—Triamcinolone—psoriasis	0.000176	0.0021	CcSEcCtD
Orphenadrine—Dizziness—Hydrocortisone—psoriasis	0.000175	0.00209	CcSEcCtD
Orphenadrine—Nausea—Mycophenolate mofetil—psoriasis	0.000172	0.00206	CcSEcCtD
Orphenadrine—Headache—Prednisolone—psoriasis	0.000169	0.00202	CcSEcCtD
Orphenadrine—Constipation—Prednisone—psoriasis	0.000168	0.00201	CcSEcCtD
Orphenadrine—Vomiting—Hydrocortisone—psoriasis	0.000168	0.00201	CcSEcCtD
Orphenadrine—Confusional state—Methotrexate—psoriasis	0.000166	0.00198	CcSEcCtD
Orphenadrine—Headache—Hydrocortisone—psoriasis	0.000165	0.00198	CcSEcCtD
Orphenadrine—Dizziness—Triamcinolone—psoriasis	0.000164	0.00196	CcSEcCtD
Orphenadrine—Anaphylactic shock—Methotrexate—psoriasis	0.000164	0.00196	CcSEcCtD
Orphenadrine—Feeling abnormal—Prednisone—psoriasis	0.000162	0.00193	CcSEcCtD
Orphenadrine—Asthenia—Dexamethasone—psoriasis	0.000162	0.00193	CcSEcCtD
Orphenadrine—Asthenia—Betamethasone—psoriasis	0.000162	0.00193	CcSEcCtD
Orphenadrine—Nausea—Prednisolone—psoriasis	0.000161	0.00192	CcSEcCtD
Orphenadrine—Pruritus—Betamethasone—psoriasis	0.00016	0.00191	CcSEcCtD
Orphenadrine—Pruritus—Dexamethasone—psoriasis	0.00016	0.00191	CcSEcCtD
Orphenadrine—Skin disorder—Methotrexate—psoriasis	0.000159	0.0019	CcSEcCtD
Orphenadrine—Vomiting—Triamcinolone—psoriasis	0.000158	0.00189	CcSEcCtD
Orphenadrine—Nausea—Hydrocortisone—psoriasis	0.000157	0.00187	CcSEcCtD
Orphenadrine—Urticaria—Prednisone—psoriasis	0.000156	0.00186	CcSEcCtD
Orphenadrine—Headache—Triamcinolone—psoriasis	0.000156	0.00186	CcSEcCtD
Orphenadrine—Dizziness—Betamethasone—psoriasis	0.000149	0.00178	CcSEcCtD
Orphenadrine—Dizziness—Dexamethasone—psoriasis	0.000149	0.00178	CcSEcCtD
Orphenadrine—Nausea—Triamcinolone—psoriasis	0.000148	0.00176	CcSEcCtD
Orphenadrine—Somnolence—Methotrexate—psoriasis	0.000146	0.00174	CcSEcCtD
Orphenadrine—Hypersensitivity—Prednisone—psoriasis	0.000145	0.00173	CcSEcCtD
Orphenadrine—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.000144	0.0435	CbGpPWpGaD
Orphenadrine—Vomiting—Dexamethasone—psoriasis	0.000143	0.00171	CcSEcCtD
Orphenadrine—Vomiting—Betamethasone—psoriasis	0.000143	0.00171	CcSEcCtD
Orphenadrine—Headache—Betamethasone—psoriasis	0.000141	0.00169	CcSEcCtD
Orphenadrine—Headache—Dexamethasone—psoriasis	0.000141	0.00169	CcSEcCtD
Orphenadrine—Asthenia—Prednisone—psoriasis	0.000141	0.00168	CcSEcCtD
Orphenadrine—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.000141	0.0426	CbGpPWpGaD
Orphenadrine—Pruritus—Prednisone—psoriasis	0.000139	0.00166	CcSEcCtD
Orphenadrine—Feeling abnormal—Methotrexate—psoriasis	0.000135	0.00162	CcSEcCtD
Orphenadrine—Nausea—Dexamethasone—psoriasis	0.000134	0.0016	CcSEcCtD
Orphenadrine—Nausea—Betamethasone—psoriasis	0.000134	0.0016	CcSEcCtD
Orphenadrine—Urticaria—Methotrexate—psoriasis	0.00013	0.00156	CcSEcCtD
Orphenadrine—Dizziness—Prednisone—psoriasis	0.00013	0.00155	CcSEcCtD
Orphenadrine—Vomiting—Prednisone—psoriasis	0.000125	0.00149	CcSEcCtD
Orphenadrine—Headache—Prednisone—psoriasis	0.000123	0.00147	CcSEcCtD
Orphenadrine—Hypersensitivity—Methotrexate—psoriasis	0.000121	0.00144	CcSEcCtD
Orphenadrine—Asthenia—Methotrexate—psoriasis	0.000118	0.00141	CcSEcCtD
Orphenadrine—Nausea—Prednisone—psoriasis	0.000117	0.00139	CcSEcCtD
Orphenadrine—Pruritus—Methotrexate—psoriasis	0.000116	0.00139	CcSEcCtD
Orphenadrine—Dizziness—Methotrexate—psoriasis	0.000109	0.0013	CcSEcCtD
Orphenadrine—Vomiting—Methotrexate—psoriasis	0.000104	0.00125	CcSEcCtD
Orphenadrine—Headache—Methotrexate—psoriasis	0.000103	0.00123	CcSEcCtD
Orphenadrine—Nausea—Methotrexate—psoriasis	9.75e-05	0.00116	CcSEcCtD
Orphenadrine—CYP3A4—Xenobiotics—CYP2S1—psoriasis	6.52e-05	0.0198	CbGpPWpGaD
Orphenadrine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	5.96e-05	0.0181	CbGpPWpGaD
Orphenadrine—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	5.88e-05	0.0178	CbGpPWpGaD
Orphenadrine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	5.84e-05	0.0177	CbGpPWpGaD
Orphenadrine—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	5.76e-05	0.0175	CbGpPWpGaD
Orphenadrine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	4.83e-05	0.0146	CbGpPWpGaD
Orphenadrine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	4.73e-05	0.0143	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—RUNX3—psoriasis	4.14e-05	0.0125	CbGpPWpGaD
Orphenadrine—GRIN2D—Alzheimers Disease—APOE—psoriasis	4.05e-05	0.0123	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—RUNX3—psoriasis	3.56e-05	0.0108	CbGpPWpGaD
Orphenadrine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	3.48e-05	0.0105	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—RUNX3—psoriasis	3.45e-05	0.0104	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—IL13—psoriasis	3.27e-05	0.0099	CbGpPWpGaD
Orphenadrine—GRIN1—Alzheimers Disease—APOE—psoriasis	2.9e-05	0.00878	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—IL13—psoriasis	2.81e-05	0.00851	CbGpPWpGaD
Orphenadrine—CHRM2—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	2.78e-05	0.00841	CbGpPWpGaD
Orphenadrine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	2.74e-05	0.0083	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—IL13—psoriasis	2.72e-05	0.00825	CbGpPWpGaD
Orphenadrine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	2.71e-05	0.00821	CbGpPWpGaD
Orphenadrine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	2.68e-05	0.00812	CbGpPWpGaD
Orphenadrine—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	2.67e-05	0.0081	CbGpPWpGaD
Orphenadrine—CYP2B6—Biological oxidations—CYP2S1—psoriasis	2.57e-05	0.00778	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—HCAR2—psoriasis	2.54e-05	0.00771	CbGpPWpGaD
Orphenadrine—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	2.53e-05	0.00767	CbGpPWpGaD
Orphenadrine—CYP2E1—Biological oxidations—CYP2S1—psoriasis	2.51e-05	0.00762	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—IL4—psoriasis	2.49e-05	0.00753	CbGpPWpGaD
Orphenadrine—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	2.48e-05	0.00751	CbGpPWpGaD
Orphenadrine—HRH1—IL-4 Signaling Pathway—SOCS1—psoriasis	2.4e-05	0.00727	CbGpPWpGaD
Orphenadrine—SLC6A2—NRF2 pathway—TGFA—psoriasis	2.39e-05	0.00725	CbGpPWpGaD
Orphenadrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	2.2e-05	0.00665	CbGpPWpGaD
Orphenadrine—CYP2E1—Tryptophan metabolism—CAT—psoriasis	2.17e-05	0.00657	CbGpPWpGaD
Orphenadrine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	2.17e-05	0.00656	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—LEP—psoriasis	2.1e-05	0.00637	CbGpPWpGaD
Orphenadrine—HRH1—IL-4 Signaling Pathway—IL4—psoriasis	2.09e-05	0.00634	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	2.06e-05	0.00623	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—IL10—psoriasis	2.04e-05	0.00619	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	2.02e-05	0.00613	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—ICAM1—psoriasis	1.97e-05	0.00598	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—NOS2—psoriasis	1.96e-05	0.00594	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—CARM1—psoriasis	1.93e-05	0.00585	CbGpPWpGaD
Orphenadrine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	1.91e-05	0.00578	CbGpPWpGaD
Orphenadrine—GRIN2D—Alzheimers Disease—TNF—psoriasis	1.87e-05	0.00567	CbGpPWpGaD
Orphenadrine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	1.87e-05	0.00566	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—RUNX3—psoriasis	1.83e-05	0.00556	CbGpPWpGaD
Orphenadrine—SLC6A2—Monoamine Transport—TNF—psoriasis	1.78e-05	0.0054	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—CARM1—psoriasis	1.77e-05	0.00538	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—IL10—psoriasis	1.76e-05	0.00532	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—CARM1—psoriasis	1.71e-05	0.00518	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—CARM1—psoriasis	1.71e-05	0.00518	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—IL10—psoriasis	1.7e-05	0.00516	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—NFKBIA—psoriasis	1.67e-05	0.00506	CbGpPWpGaD
Orphenadrine—GRIN2D—Alzheimers Disease—TP53—psoriasis	1.65e-05	0.005	CbGpPWpGaD
Orphenadrine—HRH1—IL-4 Signaling Pathway—NFKBIA—psoriasis	1.65e-05	0.005	CbGpPWpGaD
Orphenadrine—SLC6A2—SLC-mediated transmembrane transport—CP—psoriasis	1.58e-05	0.00479	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—HCAR2—psoriasis	1.57e-05	0.00475	CbGpPWpGaD
Orphenadrine—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—psoriasis	1.55e-05	0.00471	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—HCAR2—psoriasis	1.54e-05	0.00467	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—IFNG—psoriasis	1.5e-05	0.00455	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—IL13—psoriasis	1.45e-05	0.00439	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—CARM1—psoriasis	1.4e-05	0.00424	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—CXCL8—psoriasis	1.4e-05	0.00423	CbGpPWpGaD
Orphenadrine—GRIN1—EPH-Ephrin signaling—VEGFA—psoriasis	1.36e-05	0.00413	CbGpPWpGaD
Orphenadrine—HRH1—IL-4 Signaling Pathway—TYK2—psoriasis	1.35e-05	0.00409	CbGpPWpGaD
Orphenadrine—GRIN1—Alzheimers Disease—TNF—psoriasis	1.34e-05	0.00406	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—CCL20—psoriasis	1.32e-05	0.00401	CbGpPWpGaD
Orphenadrine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	1.24e-05	0.00377	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—CARM1—psoriasis	1.2e-05	0.00364	CbGpPWpGaD
Orphenadrine—GRIN1—Alzheimers Disease—TP53—psoriasis	1.18e-05	0.00358	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—CYP2S1—psoriasis	1.17e-05	0.00353	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	1.15e-05	0.00349	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—CXCL8—psoriasis	1.12e-05	0.00339	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—JUN—psoriasis	1.11e-05	0.00336	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	1.07e-05	0.00324	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—NFKB1—psoriasis	1.07e-05	0.00323	CbGpPWpGaD
Orphenadrine—HRH1—IL-4 Signaling Pathway—NFKB1—psoriasis	1.05e-05	0.00319	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	1.05e-05	0.00318	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—JUN—psoriasis	1.04e-05	0.00315	CbGpPWpGaD
Orphenadrine—CYP3A4—Tryptophan metabolism—CAT—psoriasis	1.01e-05	0.00305	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—NFKB1—psoriasis	1e-05	0.00303	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—TYK2—psoriasis	9.87e-06	0.00299	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—TNF—psoriasis	9.73e-06	0.00295	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—CXCL8—psoriasis	9.61e-06	0.00291	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—STAT3—psoriasis	9.58e-06	0.0029	CbGpPWpGaD
Orphenadrine—HRH1—IL-4 Signaling Pathway—STAT3—psoriasis	9.46e-06	0.00287	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—CXCL8—psoriasis	9.31e-06	0.00282	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—LEP—psoriasis	9.23e-06	0.0028	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—VEGFA—psoriasis	9.08e-06	0.00275	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—TYK2—psoriasis	9.07e-06	0.00275	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—IL10—psoriasis	9.06e-06	0.00275	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—JUN—psoriasis	8.93e-06	0.00271	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—HCAR2—psoriasis	8.85e-06	0.00268	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—TYK2—psoriasis	8.74e-06	0.00265	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—TYK2—psoriasis	8.74e-06	0.00265	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—HCAR2—psoriasis	8.71e-06	0.00264	CbGpPWpGaD
Orphenadrine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.67e-06	0.00263	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—JUN—psoriasis	8.66e-06	0.00262	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—NFKB1—psoriasis	8.6e-06	0.0026	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—TP53—psoriasis	8.58e-06	0.0026	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—LEP—psoriasis	8.48e-06	0.00257	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—NFKB1—psoriasis	8.33e-06	0.00252	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—LEP—psoriasis	8.18e-06	0.00248	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—LEP—psoriasis	8.18e-06	0.00248	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—CCL20—psoriasis	8.13e-06	0.00246	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—PPARG—psoriasis	8.04e-06	0.00244	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HCAR2—psoriasis	8.04e-06	0.00244	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—CP—psoriasis	8.03e-06	0.00243	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—CCL20—psoriasis	8e-06	0.00243	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HCAR2—psoriasis	7.91e-06	0.0024	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—IL6—psoriasis	7.85e-06	0.00238	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—VEGFA—psoriasis	7.8e-06	0.00236	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—TNF—psoriasis	7.78e-06	0.00236	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—CARM1—psoriasis	7.66e-06	0.00232	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—VEGFA—psoriasis	7.56e-06	0.00229	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—PPARG—psoriasis	7.39e-06	0.00224	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—TYK2—psoriasis	7.15e-06	0.00217	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—PPARG—psoriasis	7.12e-06	0.00216	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—PPARG—psoriasis	7.12e-06	0.00216	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—TYK2—psoriasis	7.04e-06	0.00213	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—VEGFA—psoriasis	6.98e-06	0.00211	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—LEP—psoriasis	6.69e-06	0.00203	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—TNF—psoriasis	6.69e-06	0.00203	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—TNF—psoriasis	6.48e-06	0.00196	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—TYK2—psoriasis	6.47e-06	0.00196	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—VEGFA—psoriasis	6.41e-06	0.00194	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—IL6—psoriasis	6.28e-06	0.0019	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—TYK2—psoriasis	6.24e-06	0.00189	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—TYK2—psoriasis	6.24e-06	0.00189	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—VEGFA—psoriasis	6.18e-06	0.00187	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—VEGFA—psoriasis	6.18e-06	0.00187	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—TYK2—psoriasis	6.15e-06	0.00186	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—PPARG—psoriasis	5.83e-06	0.00177	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—LEP—psoriasis	5.75e-06	0.00174	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—NFKB1—psoriasis	5.49e-06	0.00166	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—IL6—psoriasis	5.4e-06	0.00164	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—IL6—psoriasis	5.23e-06	0.00158	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—NDUFA5—psoriasis	5.16e-06	0.00156	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—TYK2—psoriasis	5.1e-06	0.00155	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—VEGFA—psoriasis	5.06e-06	0.00153	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—NDUFA5—psoriasis	5.06e-06	0.00153	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—NFKB1—psoriasis	5.04e-06	0.00153	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—PPARG—psoriasis	5.01e-06	0.00152	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—VEGFA—psoriasis	4.98e-06	0.00151	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—CXCL8—psoriasis	4.95e-06	0.0015	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—STAT3—psoriasis	4.93e-06	0.00149	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—NFKB1—psoriasis	4.86e-06	0.00147	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—NFKB1—psoriasis	4.86e-06	0.00147	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—IL6—psoriasis	4.83e-06	0.00146	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HCAR2—psoriasis	4.75e-06	0.00144	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HCAR2—psoriasis	4.67e-06	0.00142	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—JUN—psoriasis	4.61e-06	0.0014	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CCL20—psoriasis	4.6e-06	0.00139	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—VEGFA—psoriasis	4.58e-06	0.00139	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—STAT3—psoriasis	4.53e-06	0.00137	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CCL20—psoriasis	4.52e-06	0.00137	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	4.47e-06	0.00136	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—IL6—psoriasis	4.44e-06	0.00134	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—NFKB1—psoriasis	4.43e-06	0.00134	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—VEGFA—psoriasis	4.41e-06	0.00134	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—VEGFA—psoriasis	4.41e-06	0.00134	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP2S1—psoriasis	4.39e-06	0.00133	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—TYK2—psoriasis	4.39e-06	0.00133	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—STAT3—psoriasis	4.37e-06	0.00132	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—STAT3—psoriasis	4.37e-06	0.00132	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—VEGFA—psoriasis	4.35e-06	0.00132	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP2S1—psoriasis	4.3e-06	0.0013	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—IL6—psoriasis	4.28e-06	0.0013	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—IL6—psoriasis	4.28e-06	0.0013	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—TNF—psoriasis	4.27e-06	0.00129	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CCL20—psoriasis	4.17e-06	0.00126	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TAGAP—psoriasis	4.12e-06	0.00125	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CCL20—psoriasis	4.11e-06	0.00124	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TAGAP—psoriasis	4.05e-06	0.00123	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—VEGFA—psoriasis	4.02e-06	0.00122	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—NFKB1—psoriasis	3.98e-06	0.00121	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—TNF—psoriasis	3.92e-06	0.00119	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—TNF—psoriasis	3.78e-06	0.00115	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—TNF—psoriasis	3.78e-06	0.00115	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—VEGFA—psoriasis	3.61e-06	0.00109	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—STAT3—psoriasis	3.57e-06	0.00108	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—CXCL8—psoriasis	3.57e-06	0.00108	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—IL6—psoriasis	3.5e-06	0.00106	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—TNF—psoriasis	3.45e-06	0.00104	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—IL6—psoriasis	3.44e-06	0.00104	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—NFKB1—psoriasis	3.42e-06	0.00104	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—IL6—psoriasis	3.17e-06	0.000959	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—VEGFA—psoriasis	3.1e-06	0.00094	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—TNF—psoriasis	3.09e-06	0.000938	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—STAT3—psoriasis	3.07e-06	0.000931	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—IL6—psoriasis	3.05e-06	0.000925	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—IL6—psoriasis	3.05e-06	0.000925	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—IL6—psoriasis	3.01e-06	0.000911	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.88e-06	0.000874	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.84e-06	0.00086	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—IL6—psoriasis	2.78e-06	0.000843	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—TNF—psoriasis	2.66e-06	0.000806	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—IL6—psoriasis	2.5e-06	0.000757	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCL20—psoriasis	2.47e-06	0.000747	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCL20—psoriasis	2.43e-06	0.000735	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NDUFA5—psoriasis	2.35e-06	0.000711	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—CXCL8—psoriasis	2.2e-06	0.000666	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.19e-06	0.000663	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—CXCL8—psoriasis	2.16e-06	0.000655	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—IL6—psoriasis	2.15e-06	0.00065	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CARM1—psoriasis	2.14e-06	0.000649	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CARM1—psoriasis	2.1e-06	0.000636	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP2S1—psoriasis	1.99e-06	0.000604	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SOCS1—psoriasis	1.36e-06	0.000411	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SOCS1—psoriasis	1.34e-06	0.000405	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CAT—psoriasis	1.32e-06	0.000399	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—TYK2—psoriasis	1.29e-06	0.000392	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CAT—psoriasis	1.29e-06	0.000391	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—TYK2—psoriasis	1.27e-06	0.000386	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CXCL8—psoriasis	1.24e-06	0.000376	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CXCL8—psoriasis	1.22e-06	0.00037	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CXCL8—psoriasis	1.13e-06	0.000342	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CXCL8—psoriasis	1.11e-06	0.000336	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—APOE—psoriasis	1.02e-06	0.00031	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—APOE—psoriasis	1e-06	0.000304	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—LEP—psoriasis	1e-06	0.000304	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APOE—psoriasis	1e-06	0.000304	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—LEP—psoriasis	9.86e-07	0.000299	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APOE—psoriasis	9.86e-07	0.000299	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CARM1—psoriasis	9.74e-07	0.000295	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NFKBIA—psoriasis	9.34e-07	0.000283	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NFKBIA—psoriasis	9.19e-07	0.000278	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PPARG—psoriasis	8.92e-07	0.00027	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PPARG—psoriasis	8.74e-07	0.000265	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TYK2—psoriasis	7.65e-07	0.000232	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TYK2—psoriasis	7.52e-07	0.000228	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CXCL8—psoriasis	6.66e-07	0.000202	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CXCL8—psoriasis	6.55e-07	0.000199	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL6—psoriasis	6.33e-07	0.000192	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL6—psoriasis	6.23e-07	0.000189	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—JUN—psoriasis	6.19e-07	0.000188	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—JUN—psoriasis	6.09e-07	0.000185	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CAT—psoriasis	5.99e-07	0.000182	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NFKB1—psoriasis	5.96e-07	0.000181	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NFKB1—psoriasis	5.86e-07	0.000178	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—VEGFA—psoriasis	5.41e-07	0.000164	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—STAT3—psoriasis	5.35e-07	0.000162	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—VEGFA—psoriasis	5.32e-07	0.000161	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—STAT3—psoriasis	5.27e-07	0.00016	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOE—psoriasis	4.65e-07	0.000141	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TP53—psoriasis	4.09e-07	0.000124	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PPARG—psoriasis	4.05e-07	0.000123	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TP53—psoriasis	4.02e-07	0.000122	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL6—psoriasis	3.74e-07	0.000113	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL6—psoriasis	3.68e-07	0.000112	CbGpPWpGaD
